| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 6, 2025
The company will present clinical evidence at ATTD exploring challenges faced by women living with type 1 diabetes, from menstruation to pregestational diabetes
-
Mar 5, 2025
Taking the patient experience to the next stage
-
Feb 26, 2025
St. Francis Hospital in New York performs the first patient procedure in clinical trial for coronary artery disease
-
Jan 23, 2025
Study shows 67% mean reduction in Low-back Visual Analog Scale (VAS) pain score at 12 months; 87% of subjects had meaningful improvements in three or more quality of life (QoL) domains
Data to be presented at the North American Neuromodulation Society (NANS) Annual Meeting 2025; In all, Medtronic to highlight 22 poster and oral scientific data presentations
-
Jan 17, 2025
Data include durability of PulseSelect integrated with the Affera system, same day discharge and zero fluoroscopy with Affera and Sphere-9™ Catheter
Highlights underscore positive momentum of commercial launch of Affera in the U.S. and continued strong adoption of PulseSelect globally
Real-world use continues to demonstrate safety, efficacy and efficiency of both PFA technologies amid global expansion